virus-like particle technology

Latest Headlines

Latest Headlines

Mitsubishi Tanabe set to buy Medicago for VLP technology

Life science stocks are hot, venture capitalists have renewed their interest in biotech and a host of big companies are on the hunt for startup vaccine makers with novel products and technology. Medicago is the latest developmental vaccine maker to attract a bid. 

Bird flu vaccine hits the clinic

Novavax saw a climb in its share value on the announcement that it has started enrollment of a Phase I clinical trial of its A/H5N1 vaccine to prevent bird flu.